Journal
EUROPEAN JOURNAL OF ENDOCRINOLOGY
Volume 177, Issue 3, Pages R113-R124Publisher
BIOSCIENTIFICA LTD
DOI: 10.1530/EJE-17-0216
Keywords
-
Categories
Ask authors/readers for more resources
In contrast to the clear indication for surgical treatment in symptomatic patients with clinically nonfunctioning pituitary adenomas (NFPA), there are no randomized controlled studies comparing therapeutic strategies such as watchful waiting, irradiation or medical therapy for the management of NFPA after surgery. Further, no medical therapy is currently approved for the treatment of NFPA. In this review, we summarize accumulating data on medications currently approved for secreting pituitary adenomas, used off-label in patients with NFPA. Perspectives on overall treatment optimization and potential future therapies are also detailed.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available